×
This study aims to improve the solubility and dissolution rate of alectinib (ALB), a tyrosine kinase inhibitor commonly used for treating non-small-cell ...
Missing: 2F1420- 3049% 2F27% 2F22% 2F7974
People also ask
Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 14.6 days after submission; acceptance to publication ...
Missing: 2Fwww. 2F1420- 2F27% 2F22% 2F7974